Nonviral Minicircle Vector for SOX Gene Cartilage Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for regenerating damaged articular cartilage are limited by the difficulty in replicating and differentiating adult stem cells, particularly in young patients, and the use of viral vectors for genetic manipulation poses safety concerns.
Innovation Solution
A non-viral minicircle vector system expressing SOX5, SOX6, or SOX9 genes is developed, which does not include a bacterial backbone, allowing for the simultaneous regulation of these genes under one promoter, enhancing chondrogenic differentiation efficiency in stem cells without the need for viral vectors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viral vectors are used for genetic manipulation to promote chondrogenic differentiation, then gene transfer efficiency is improved, but safety concerns increase due to potential immunogenicity and insertional mutagenesis
Solution Approach 1:
The invention extracts and removes the bacterial backbone from the plasmid vector, retaining only the essential eukaryotic expression elements (promoter, multiple cloning site, polyadenylation signal). This creates a minicircle vector that eliminates bacterial DNA sequences that could trigger immune responses or cause insertional mutagenesis, while preserving the ability to efficiently transfer and express therapeutic genes in eukaryotic cells
Solution Approach 2:
The invention changes the structural parameters of the vector by reducing its size and eliminating unnecessary components. The minicircle vector consists only of essential eukaryotic regulatory elements, transforming the vector from a complex plasmid with bacterial origins of replication and antibiotic resistance genes to a streamlined circular DNA molecule optimized for eukaryotic gene expression with improved safety profile
2Adaptability or versatility
If multiple SOX genes are separately regulated with individual promoters, then each gene can be independently controlled, but device complexity increases
Solution Approach 1:
The invention merges multiple gene expression units into a single polycistronic construct where SOX5, SOX6, and SOX9 genes are arranged in tandem under the control of a single promoter. The 2A self-cleaving peptide sequences are inserted between adjacent genes to enable ribosomal skip during translation, allowing individual protein expression from a unified transcriptional unit. This reduces vector complexity while maintaining the ability to independently control each gene's expression
3Stability of the object's composition
If complete plasmid vectors including bacterial backbone are used, then vector stability during bacterial propagation is improved, but unnecessary bacterial genes are transferred to target cells
Solution Approach 1:
The invention extracts and removes the bacterial backbone (origin of replication, antibiotic resistance genes, bacterial promoter sequences) from the complete plasmid vector. The resulting minicircle vector contains only essential eukaryotic expression elements, eliminating unnecessary bacterial DNA that would otherwise be co-transferred to target cells and potentially cause adverse effects while maintaining sufficient stability for the intended application
Data Source
AI summary
The present invention relates to a non-viral minicircle vector expressing a SOX gene, a stem cell into which the vector is introduced, a pharmaceutical composition for preventing or treating a cartilage disease, including the stem cell, and a method for constructing the vector. The transformation of mesenchymal stem cells with MC/SOX-Trio or MC/SOX-Duo, which is a non-viral minicircle vector according to the present invention, can completely exclude the necessity of expensive growth factors that have been indispensably used in inducing the differentiation of mesenchymal stem cells into chondrocytes. Accordingly, the mesenchymal stem cells transformed therewith, when implanted in vivo, can differentiate into chondrocytes by themselves, and thus have an advantage capable of simplifying the existing complicated steps of culturing cells to induce differentiation and then transplanting the cells.Further, unlike existing vector systems in which antibiotic-resistant genes and other bacteria-derived exogenous genes are simultaneously transferred to cells even after transformation, the vector of the present invention minimizes transfer of unnecessary genes into target cells by allowing two or three SOX genes necessary only for differentiation into chondrocytes to be regulated under one promoter, and thus can be utilized as a non-viral vector system in the most advantageous form for use in clinical application of stem cell-gene therapeutic agents.